William Blair Maintains Arcellx(ACLX.US) With Buy Rating
William Blair Sticks to Its Buy Rating for Arcellx Inc (ACLX)
Arcellx, Inc. (ACLX): Among Takeover Rumors Hedge Funds Are Buying
Here's Why We're Not At All Concerned With Arcellx's (NASDAQ:ACLX) Cash Burn Situation
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday
Analysts Are Bullish on These Healthcare Stocks: Illumina (ILMN), Arcellx Inc (ACLX)
Arcellx Inc Announces Board Changes for Strategic Growth
Arcellx: Derek Yoon Steps Dn From the Bd >ACLX
Arcellx Appoints Andrew Galligan and Kristin Myers to Its Board of Directors
Barclays Maintains Arcellx(ACLX.US) With Buy Rating, Maintains Target Price $115
Downgrade: Here's How Analysts See Arcellx, Inc. (NASDAQ:ACLX) Performing In The Near Term
Stifel Maintains Arcellx(ACLX.US) With Buy Rating, Cuts Target Price to $118
We're Not Worried About Arcellx's (NASDAQ:ACLX) Cash Burn
Arcellx, Inc.'s (NASDAQ:ACLX) Business Is Yet to Catch Up With Its Share Price
Have Arcellx Insiders Been Selling Stock?
Arcellx Reports Promising 2024 Financial and Clinical Progress
Bank of America Securities Keeps Their Buy Rating on Arcellx Inc (ACLX)
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $105 to $134
Arcellx Inc: Buy Rating Affirmed on Promising Anito-cel Therapy and Strong Financial Position
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcellx Inc (ACLX) and PTC Therapeutics (PTCT)